Many of the largest drugmakers may be exempt from Medicare pilot programs intended to force them to lower some of their prices, potentially undermining the effort and depriving American patients of cheaper drugs. Several of the 14 pharmaceutical companies that have struck individual drug-pricing deals with the White House said they are exempt from the…
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. The NIH director did the Pete & Bobby fitness challenge, but I didn’t see Jay Bhattacharya do any pull-ups. And you can decide what…
WASHINGTON — A possible Trump administration effort to change the childhood vaccine schedule left hospital leaders, health policymakers, and pediatricians scrambling to navigate what could be the most significant changes to the American vaccine program in decades. The administration had planned to announce on Friday moves to pare down the number of shots on the…
new video loaded: President Trump Reclassifies Marijuana With Executive Order transcript Back transcript President Trump Reclassifies Marijuana With Executive Order Marijuana was downgraded from a Schedule I drug to a Schedule III drug on Thursday. The reclassification does not legalize cannabis, but it does ease restrictions on the substance and allows for more research. Today,…
WASHINGTON — Several drugmakers are expected to sign pricing agreements with the Trump administration on Friday, according to four people familiar with the plans, who were not authorized to speak publicly. The agreements would be the latest in a series of deals in which pharmaceutical companies agree to lower drug prices and invest more domestically…
WASHINGTON — As the Trump administration moves ahead on what could be its most wide-reaching vaccine changes yet, the makers of the shots are weighing their options — and privately warning that officials could severely limit access to key vaccines and upend the childhood vaccine schedule for years to come. U.S. health authorities, under the…
WASHINGTON — When President Trump announced the administration’s deal to cut prices for weight-loss drugs, he proclaimed that “you will pay the lowest price anywhere in the world.” But state Medicaid programs might already be getting lower prices, according to a research firm. Most-favored nation pricing is the main feature of the five deals that the…
WASHINGTON — Health Secretary Robert F. Kennedy Jr. was uncharacteristically chummy with pharma executives at the White House on Thursday as he cheered the Trump administration’s plan for lowering obesity medication prices. Kennedy has railed against drugmakers in the past, and his lifestyle-focused “Make America Healthy Again” movement has opposed Medicare coverage of GLP-1 weight loss…
ANDREW CABALLERO-REYNOLDS/AFP via Getty Images Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at danielp.100. Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry…
WASHINGTON — The Trump administration is nearing deals with Eli Lilly and Novo Nordisk to lower the prices of their weight loss drugs and expand access to them, people familiar with the talks told STAT. The companies have been close to a deal for weeks, one lobbyist with knowledge of the negotiations said, echoing others who…